Institutional Ownership
Invesco Exchange Traded Fd T
CUSIP 46137V787BIOTECHNOLOGYPBEQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
99
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Morgan Stanley | 131.8K | $10.43M |
| 2 | United Capital Financial Advisors, LLC | 102.0K | $8.08M |
| 3 | Lpl Financial LLC | 86.7K | $6.87M |
| 4 | Ubs Group AG | 69.0K | $5.46M |
| 5 | Royal Bank Of Canada | 59.3K | $4.70M |
| 6 | Bank Of America Corp /De/ | 59.3K | $4.69M |
| 7 | Wells Fargo & Company/Mn | 39.3K | $3.11M |
| 8 | Gerber Kawasaki Wealth & Investment Management | 35.2K | $2.79M |
| 9 | Yhb Investment Advisors, Inc. | 24.4K | $1.93M |
| 10 | Cetera Investment Advisers | 23.1K | $1.83M |